1. Home
  2. BLLN vs IPGP Comparison

BLLN vs IPGP Comparison

Compare BLLN & IPGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

N/A

Current Price

$93.00

Market Cap

4.4B

Sector

Health Care

ML Signal

N/A

Logo IPG Photonics Corporation

IPGP

IPG Photonics Corporation

HOLD

Current Price

$76.01

Market Cap

3.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
IPGP
Founded
2016
1990
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.6B
IPO Year
2025
2000

Fundamental Metrics

Financial Performance
Metric
BLLN
IPGP
Price
$93.00
$76.01
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$126.71
$131.40
AVG Volume (30 Days)
797.8K
541.6K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
103.40
117.85
EPS
0.48
0.16
Revenue
$305,112,000.00
$1,003,777,000.00
Revenue This Year
$46.29
$12.18
Revenue Next Year
$30.14
$8.44
P/E Ratio
$198.23
$482.81
Revenue Growth
99.97
2.73
52 Week Low
$61.96
$69.41
52 Week High
$150.44
$155.82

Technical Indicators

Market Signals
Indicator
BLLN
IPGP
Relative Strength Index (RSI) 39.93 40.57
Support Level $88.38 $71.68
Resistance Level $95.82 $80.03
Average True Range (ATR) 4.51 3.87
MACD 0.13 0.11
Stochastic Oscillator 47.48 36.65

Price Performance

Historical Comparison
BLLN
IPGP

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About IPGP IPG Photonics Corporation

IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, laser and non-laser systems, fiber amplifiers, diode lasers, and related optical components. Its products are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. The company sells its products globally to original equipment manufacturers (OEMs), system integrators, and end users. Additionally, it manufactures complementary products used with its lasers, including optical delivery cables, fiber couplers, beam switches, optical processing heads, in-line sensors, and chillers. Geographically, the company generates maximum revenue from North America, followed by China, Japan, Germany, and other markets.

Share on Social Networks: